Skip to Main Content

Hadassah Medical Center: Mishani Eyal

Last updated September 2023 - Hadassah Medical Center

List of Publications

1.

Grievink H, Shamni O, Krajewski S, Steczek Ł, Gründemann D, Mishani E, et al. Organic Cation Transporter-Mediated Accumulation of Quinolinium Salts in the LV Myocardium of Rodents. Molecular Imaging and Biology [Internet]. 2022;24(5):1–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85128448668&doi=10.1007%252fs11307-022-01728-y&partnerID=40&md5=12d0f67f09b192ef01de33f6a199ab83

2.

Orevi M, Ben-Haim S, Abourbeh G, Chicheportiche A, Mishani E, Yutkin V, et al. False Positive Findings of [18F]PSMA-1007 PET/CT in Patients After Radical Prostatectomy with Undetectable Serum PSA Levels. Frontiers in Surgery [Internet]. 2022;9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85134043734&doi=10.3389%252ffsurg.2022.943760&partnerID=40&md5=b9eee02e7926d73adaad549bd48b927e

3.

Kuten J, Levine C, Shamni O, Pelles S, Wolf I, Lahat G, et al. Head-to-head comparison of [68Ga]Ga-FAPI-04 and [18F]-FDG PET/CT in evaluating the extent of disease in gastric adenocarcinoma. European Journal of Nuclear Medicine and Molecular Imaging [Internet]. 2022;49(2):743–50. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85111124065&doi=10.1007%252fs00259-021-05494-x&partnerID=40&md5=c67b321c74a005880aa352b8d83b0e2b

4.

Shamni O, Grievink H, Kolevzon N, Krajewski S, Steczek L, Meltzer E, et al. Development and preclinical evaluation of novel fluorinated ammonium salts for PET myocardial perfusion imaging. Scientific Reports [Internet]. 2021;11(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85116317829&doi=10.1038%252fs41598-021-99212-0&partnerID=40&md5=6d2715ed979ba056c82d7b10246fa530

5.

Walg J, Feldman J, Azarzar A, Mishani E, Orion I. Cyclotron-produced neutrons measurements using chlorine activation. Nuclear Instruments and Methods in Physics Research, Section B: Beam Interactions with Materials and Atoms [Internet]. 2021;503:1–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85109931332&doi=10.1016%252fj.nimb.2021.07.001&partnerID=40&md5=ab00640602ecdeb51678284295868067

6.

Orevi M, Shamni O, Zalcman N, Chicheportiche A, Mordechai A, Moscovici S, et al. [18F]-FDHT PET/CT as a tool for imaging androgen receptor expression in high-grade glioma. Neuro-Oncology Advances [Internet]. 2021;3(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85116612657&doi=10.1093%252fnoajnl%252fvdab019&partnerID=40&md5=c3d5bd44b0a9351cf475ae7f0a078209

7.

Kuten J, Fahoum I, Savin Z, Shamni O, Gitstein G, Hershkovitz D, et al. Head-to-head comparison of 68Ga-PSMA-11 with 18F-PSMA-1007 PET/CT in staging prostate cancer using histopathology and immunohistochemical analysis as a reference standard. Journal of Nuclear Medicine [Internet]. 2020;61(4):527–32. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082979565&doi=10.2967%252fJNUMED.119.234187&partnerID=40&md5=e9897c14831610b08a26830b72b9a19a

8.

Shamni O, Grievink H, Itamar B, Mishani E, Abourbeh G. Development of a Fluorinated Analogue of Erlotinib for PET Imaging of EGFR Mutation–Positive NSCLC. Molecular Imaging and Biology [Internet]. 2019;21(4):696–704. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85055982038&doi=10.1007%252fs11307-018-1286-8&partnerID=40&md5=68fe65775511d378e8c0acb666e2d993

9.

Shamni O, Nebeling B, Grievink H, Mishani E. Fine-tuning of the automated [18F]PSMA-1007 radiosynthesis. Journal of Labelled Compounds and Radiopharmaceuticals [Internet]. 2019;62(6):252–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85067685631&doi=10.1002%252fjlcr.3732&partnerID=40&md5=20287f1b4f9329f8a1f72651a68f23ed

10.

Kesler M, Levine C, Hershkovitz D, Mishani E, Menachem Y, Lerman H, et al. 68 Ga-labeled prostate-specific membrane antigen is a novel PET/CT tracer for imaging of hepatocellular carcinoma: A prospective pilot study. Journal of Nuclear Medicine [Internet]. 2019;60(2):185–91. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060934184&doi=10.2967%252fjnumed.118.214833&partnerID=40&md5=2c79906563daecf06d5b87c24487b3f2

11.

Dondi M, Torres L, Marengo M, Massardo T, Mishani E, Van Zyl Ellmann A, et al. Comprehensive Auditing in Nuclear Medicine Through the International Atomic Energy Agency Quality Management Audits in Nuclear Medicine Program. Part 2: Analysis of Results. Seminars in Nuclear Medicine [Internet]. 2017;47(6):687–93. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85026229795&doi=10.1053%252fj.semnuclmed.2017.07.004&partnerID=40&md5=594569ccd7977b37799b4f2010f2fb29

12.

Dondi M, Torres L, Marengo M, Massardo T, Mishani E, Van Zyl Ellmann A, et al. Comprehensive Auditing in Nuclear Medicine Through the International Atomic Energy Agency Quality Management Audits in Nuclear Medicine (QUANUM) Program. Part 1: the QUANUM Program and Methodology. Seminars in Nuclear Medicine [Internet]. 2017;47(6):680–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85025641840&doi=10.1053%252fj.semnuclmed.2017.07.003&partnerID=40&md5=625ddcb573106f64d051abeb2d2f7e05

13.

Petrulli JR, Hansen SB, Abourbeh G, Yaqub M, Bahce I, Holden D, et al. A multi species evaluation of the radiation dosimetry of [11C]erlotinib, the radiolabeled analog of a clinically utilized tyrosine kinase inhibitor. Nuclear Medicine and Biology [Internet]. 2017;47:56–61. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85009992375&doi=10.1016%252fj.nucmedbio.2016.12.009&partnerID=40&md5=f80de510222bc256e5b549dc25a6abc7

14.

Dreifuss T, Motiei M, Betzer O, Popovtzer A, Abourbeh G, Mishani E, et al. Glucose-functionalized gold nanoparticles as a metabolically targeted CT contrast agent for distinguishing tumors from non-malignant metabolically active processes. In: Progress in Biomedical Optics and Imaging - Proceedings of SPIE [Internet]. 2017. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020300746&doi=10.1117%252f12.2249850&partnerID=40&md5=09de964844fe58bfb698178b58fd98ce

15.

Weiss O, Kaufman R, Mishani E, Inbal A. Ocular vessel patterning in zebrafish is indirectly regulated by Hedgehog signaling. International Journal of Developmental Biology [Internet]. 2017;61(3–5):277–84. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020241363&doi=10.1387%252fijdb.160273ai&partnerID=40&md5=cfccd33c794687dc93cb89bd3acab62c

16.

Weinstein AM, Freedman N, Greif J, Yemini Z, Mishani E, London E, et al. Negative association of pretreatment cigarette use with smoking-induced striatal dopamine release in smokers receiving bupropion treatment. American Journal on Addictions [Internet]. 2016;25(6):486–92. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84983448614&doi=10.1111%252fajad.12419&partnerID=40&md5=f9081cad4030f24ccd07572f8b045e1f

17.

Motiei M, Dreifuss T, Betzer O, Panet H, Popovtzer A, Santana J, et al. Differentiating between Cancer and Inflammation: A Metabolic-Based Method for Functional Computed Tomography Imaging. ACS Nano [Internet]. 2016;10(3):3469–77. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84961941254&doi=10.1021%252facsnano.5b07576&partnerID=40&md5=1c03521f4240228f1964785807580c82

18.

Dissoki S, Abourbeh G, Salnikov O, Mishani E, Jacobson O. PET Molecular Imaging of Angiogenesis with a Multiple Tyrosine Kinase Receptor-Targeted Agent in a Rat Model of Myocardial Infarction. Molecular Imaging and Biology [Internet]. 2015;17(2):222–30. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84924546087&doi=10.1007%252fs11307-014-0790-8&partnerID=40&md5=a871d5ddf4f5657ca67a2e5af650a3c7

19.

Abourbeh G, Itamar B, Salnikov O, Beltsov S, Mishani E. Identifying erlotinib-sensitive non-small cell lung carcinoma tumors in mice using [11C]erlotinib PET. EJNMMI Research [Internet]. 2015;5(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84923804375&doi=10.1186%252fs13550-014-0080-0&partnerID=40&md5=bb7bc4fe0eefabe7fbdea88cc5822c67

20.

Orevi M, Freedman N, Mishani E, Bocher M, Jacobson O, Krausz Y. Localization of parathyroid adenoma by 11C-Choline PET/CT preliminary results. Clinical Nuclear Medicine [Internet]. 2014;39(12):1033–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84922394504&doi=10.1097%252fRLU.0000000000000607&partnerID=40&md5=8fc4d25d4bafa62241e4d88424547a36

21.

Jacobson O, Abourbeh G, Tsvirkun D, Mishani E. Rat Imaging and In Vivo Stability Studies using [11C]-Dimethyl-Diphenyl Ammonium, a Candidate Agent for PET-Myocardial Perfusion Imaging. Nuclear Medicine and Biology [Internet]. 2013;40(8):967–73. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84886280166&doi=10.1016%252fj.nucmedbio.2013.07.002&partnerID=40&md5=47300e9c78601c8a0d518c589dc4dd66

22.

Kepe V, Moghbel MC, Långströmd B, Zaidi H, Vinters HV, Huang SC, et al. Amyloid-β positron emission tomography imaging probes: A critical review. Journal of Alzheimer’s Disease [Internet]. 2013;36(4):613–31. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84881462432&doi=10.3233%252fJAD-130485&partnerID=40&md5=2cc5655ede08c171b7d25089a86c5fad

23.

Kesner AL, Abourbeh G, Mishani E, Chisin R, Tshori S, Freedman N. Gating, enhanced gating, and beyond: Information utilization strategies for motion management, applied to preclinical PET. EJNMMI Research [Internet]. 2013;3(1):1–15. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878796448&doi=10.1186%252f2191-219X-3-29&partnerID=40&md5=102776b94f0ee9cf83087130600c0450

24.

Ilovich O, Abourbeh G, Bocher M, Freedman N, Billauer H, Dotan S, et al. Structure-activity relationship and preclinical evaluation of carbon-11-labeled ammonium salts as PET-myocardial perfusion imaging agents. Molecular Imaging and Biology [Internet]. 2012;14(5):625–36. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84870409266&doi=10.1007%252fs11307-011-0539-6&partnerID=40&md5=c56946066d85e4826c8514167b79a557

25.

Abourbeh G, Shir A, Mishani E, Ogris M, Rödl W, Wagner E, et al. PolyIC GE11 polyplex inhibits EGFR-overexpressing tumors. IUBMB Life [Internet]. 2012;64(4):324–30. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84859075506&doi=10.1002%252fiub.1002&partnerID=40&md5=c9fb0417e329e1fefc4dc40b919620d8

26.

Orevi M, Klein M, Mishani E, Chisin R, Freedman N, Gofrit ON. 11C-acetate PET/CT in bladder urothelial carcinoma: Intraindividual comparison with 11C-choline. Clinical Nuclear Medicine [Internet]. 2012;37(4):e67–72. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84858146930&doi=10.1097%252fRLU.0b013e31824786e7&partnerID=40&md5=7471dcce58a7956b95d05dbb99683f74

27.

Gruzman A, Elgart A, Viskind O, Billauer H, Dotan S, Cohen G, et al. Antihyperglycaemic activity of 2,4:3,5-dibenzylidene-D-xylose-diethyl dithioacetal in diabetic mice. Journal of Cellular and Molecular Medicine [Internet]. 2012;16(3):593–603. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84857019474&doi=10.1111%252fj.1582-4934.2011.01340.x&partnerID=40&md5=087b245ac640d416a748073f761413be

28.

Krausz Y, Rubinstein R, Appelbaum L, Mishani E, Orevi M, Fraenkel M, et al. Ga-68 DOTA-NOC uptake in the pancreas: Pathological and physiological patterns. Clinical Nuclear Medicine [Internet]. 2012;37(1):57–62. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84856436096&doi=10.1097%252fRLU.0b013e3182393404&partnerID=40&md5=a9e7282953492bb2680c62bcf30ac430

29.

Magenheim J, Ilovich O, Lazarus A, Klochendler A, Ziv O, Werman R, et al. Blood vessels restrain pancreas branching, differentiation and growth. Development [Internet]. 2011;138(21):4743–52. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-80054002188&doi=10.1242%252fdev.066548&partnerID=40&md5=cf991e83d63f3fd4b2936e573b26ffbe

30.

Lazarus A, Del-Moral PM, Ilovich O, Mishani E, Warburton D, Keshet E. A perfusion-independent role of blood vessels in determining branching stereotypy of lung airways. Development [Internet]. 2011;138(11):2359–68. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-79956320721&doi=10.1242%252fdev.060723&partnerID=40&md5=a68021821af6580f402beffed3bbb545

31.

Krausz Y, Freedman N, Rubinstein R, Lavie E, Orevi M, Tshori S, et al. 68Ga-DOTA-NOC PET/CT imaging of neuroendocrine tumors: Comparison with 111In-DTPA-octreotide (OctreoScan®). Molecular Imaging and Biology [Internet]. 2011;13(3):583–93. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-79956194831&doi=10.1007%252fs11307-010-0374-1&partnerID=40&md5=06cbf93eabad2070e29285ef612d233c

32.

Ilovich O, Billauer H, Dotan S, Freedman NMT, Bocher M, Mishani E. Novel and simple carbon-11-labeled ammonium salts as pet agents for myocardial perfusion imaging. Molecular Imaging and Biology [Internet]. 2011;13(1):128–39. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-79551609819&doi=10.1007%252fs11307-010-0336-7&partnerID=40&md5=ba5368749271afbd122088bcf0e3f506

33.

Dissoki S, Hagooly A, Elmachily S, Mishani E. Labeling approaches for the GE11 peptide, an epidermal growth factor receptor biomarker. Journal of Labelled Compounds and Radiopharmaceuticals [Internet]. 2011;54(11):693–701. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-80054793175&doi=10.1002%252fjlcr.1910&partnerID=40&md5=73ed9040e9667d44bb0757a8cdf2eb57

34.

Sand FW, Hörnblad A, Johansson JK, Lorén C, Edsbagge J, Ståhlberg A, et al. Growth-limiting role of endothelial cells in endoderm development. Developmental Biology [Internet]. 2011;352(2):267–77. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-79953028801&doi=10.1016%252fj.ydbio.2011.01.026&partnerID=40&md5=f08a57a57eae7f329f99131589862ee1

35.

Pantaleo MA, Mishani E, Nanni C, Landuzzi L, Boschi S, Nicoletti G, et al. Evaluation of modified PEG-anilinoquinazoline derivatives as potential agents for EGFR imaging in cancer by small animal PET. Molecular Imaging and Biology [Internet]. 2010;12(6):616–25. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-78650516740&doi=10.1007%252fs11307-010-0315-z&partnerID=40&md5=f7d7f3de556426d6fbfc91fbedf89081

36.

Cohen O, Mishani E, Rozen S. From carboxylic acids to the trifluoromethyl group using BrF3. Tetrahedron [Internet]. 2010;66(20):3579–82. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-77950858792&doi=10.1016%252fj.tet.2010.03.045&partnerID=40&md5=73d9d1376ce993def2d4b1e25c672ded

37.

Ilovich O, Billauer H, Dotan S, Mishani E. Labeled 3-aryl-4-indolylmaleimide derivatives and their potential as angiogenic PET biomarkers. Bioorganic and Medicinal Chemistry [Internet]. 2010;18(2):612–20. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-76449091096&doi=10.1016%252fj.bmc.2009.12.004&partnerID=40&md5=c9113e1a9c801d9f13a4f0a5ca69a2ee

38.

Mishani E, Hagooly A. Strategies for molecular imaging of epidermal growth factor receptor tyrosine kinase in cancer. Journal of Nuclear Medicine [Internet]. 2009;50(8):1199–202. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-68249160667&doi=10.2967%252fjnumed.109.062117&partnerID=40&md5=57ab6453092a66fae9dd2e39da85f162

39.

Ruvinsky I, Katz M, Dreazen A, Gielchinsky Y, Saada A, Freedman N, et al. Mice deficient in ribosomal protein S6 phosphorylation suffer from muscle weakness that reflects a growth defect and energy deficit. PLoS ONE [Internet]. 2009;4(5). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-66049157014&doi=10.1371%252fjournal.pone.0005618&partnerID=40&md5=5d260ebe9c88d4324d77c77a6852bf54

40.

Ilovich O, Åberg O, Långström B, Mishania E. Rhodium-mediated [11C]Carbonylation: A library of N-phenyl-N′-4-(4-quinolyloxy)-phenyl-[11C]-urea derivatives as potential PET angiogenic probes. Journal of Labelled Compounds and Radiopharmaceuticals [Internet]. 2009;52(5):151–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-65649128115&doi=10.1002%252fjlcr.1582&partnerID=40&md5=d4f315f2acc73b06fa1776152c18cc06

41.

Afergan E, Epstein H, Koroukhov N, Klein M, Litchi A, Mishani E, et al. Biodistribution and imaging studies of 67Ga-labeled liposomes in rabbits with a vascular injury. Journal of Drug Delivery Science and Technology [Internet]. 2009;19(4):263–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-69249113493&doi=10.1016%2fS1773-2247%2809%2950050-0&partnerID=40&md5=22d7ad7dc1f9f16f0bcfcb5a2e83f87f

42.

Dissoki S, Eshet R, Billauer H, Mishani E. Modified PEG-anilinoquinazoline derivatives as potential EGFR PET agents. Journal of Labelled Compounds and Radiopharmaceuticals [Internet]. 2009;52(2):41–52. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-63049116842&doi=10.1002%252fjlcr.1569&partnerID=40&md5=5f0fc5be834a5d6184fef91ba89c7915

43.

Mishani E, Abourbeh G, Eiblmaier M, Anderson CJ. Imaging of EGFR and EGFR tyrosine kinase overexpression in tumors by nuclear medicine modalities. Current Pharmaceutical Design [Internet]. 2008;14(28):2983–98. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-58149392589&doi=10.2174%252f138161208786404326&partnerID=40&md5=79c151dfd0d32ac8f7ddaa64faf54d6d

44.

Ben-Daniel R, Deuther-Conrad W, Scheunemann M, Steinbach J, Brust P, Mishani E. Carbon-11 labeled indolylpropylamine analog as a new potential PET agent for imaging of the serotonin transporter. Bioorganic and Medicinal Chemistry [Internet]. 2008;16(12):6364–70. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-44649101993&doi=10.1016%252fj.bmc.2008.05.006&partnerID=40&md5=85408cbb4729be877031fb307a72a854

45.

Ilovich O, Jacobson O, Aviv Y, Litchi A, Chisin R, Mishani E. Formation of fluorine-18 labeled diaryl ureas-labeled VEGFR-2/PDGFR dual inhibitors as molecular imaging agents for angiogenesis. Bioorganic and Medicinal Chemistry [Internet]. 2008;16(8):4242–51. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-42149182580&doi=10.1016%252fj.bmc.2008.02.081&partnerID=40&md5=d250fd7212a840bbd47f7c7e9af8de95

46.

Jacobson O, Mishani E. [11C]-dimethylamine as a labeling agent for PET biomarkers. Applied Radiation and Isotopes [Internet]. 2008;66(2):188–93. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-37149055769&doi=10.1016%252fj.apradiso.2007.08.012&partnerID=40&md5=e54860896da2636f8cfe2da64f69ec20

47.

Even-Sapir E, Mishani E, Flusser G, Metser U. 18F-Fluoride Positron Emission Tomography and Positron Emission Tomography/Computed Tomography. Seminars in Nuclear Medicine [Internet]. 2007;37(6):462–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-34848895720&doi=10.1053%252fj.semnuclmed.2007.07.002&partnerID=40&md5=b936a8c2dcae20925c641a7e9db705db

48.

Dissoki S, Aviv Y, Laky D, Abourbeh G, Levitzki A, Mishani E. The effect of the [18F]-PEG group on tracer qualification of [4-(phenylamino)-quinazoline-6-YL]-amide moiety-An EGFR putative irreversible inhibitor. Applied Radiation and Isotopes [Internet]. 2007;65(10):1140–51. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-34548217626&doi=10.1016%252fj.apradiso.2007.04.014&partnerID=40&md5=53673ba90f85fd92450349264a4d175d

49.

Mishani E, Abourbeh G. Cancer molecular imaging: Radionuclide-based biomarkers of the epidermal growth factor receptor (EGFR). Current Topics in Medicinal Chemistry [Internet]. 2007;7(18):1755–72. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-36248944183&doi=10.2174%252f156802607782507457&partnerID=40&md5=2868b545ad1cba9437c7803fafd4e141

50.

Abourbeh G, Dissoki S, Jacobson O, Litchi A, Daniel RB, Laki D, et al. Evaluation of radiolabeled ML04, a putative irreversible inhibitor of epidermal growth factor receptor, as a bioprobe for PET imaging of EGFR-overexpressing tumors. Nuclear Medicine and Biology [Internet]. 2007;34(1):55–70. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33845935326&doi=10.1016%252fj.nucmedbio.2006.10.012&partnerID=40&md5=33df3a16f4edf6f7ec4b36006c055956

51.

Shushan A, Ben-Bassat H, Mishani E, Laufer N, Klein BY, Rojansky N. Inhibition of leiomyoma cell proliferation in vitro by genistein and the protein tyrosine kinase inhibitor TKS050. Fertility and Sterility [Internet]. 2007;87(1):127–35. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33845742037&doi=10.1016%252fj.fertnstert.2006.05.056&partnerID=40&md5=be89a6005a018c3a7c6737445143ba5a

52.

Gofrit ON, Mishani E, Orevi M, Klein M, Freedman N, Pode D, et al. Contribution of 11C-Choline Positron Emission Tomography/Computerized Tomography to Preoperative Staging of Advanced Transitional Cell Carcinoma. Journal of Urology [Internet]. 2006;176(3):940–4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33746542141&doi=10.1016%252fj.juro.2006.04.018&partnerID=40&md5=9575ad7df7a3049d3b46ac35ec3f78ed

53.

Jacobson O, Laky D, Carlson KE, Elgavish S, Gozin M, Even-Sapir E, et al. Chiral dimethylamine flutamide derivatives-modeling, synthesis, androgen receptor affinities and carbon-11 labeling. Nuclear Medicine and Biology [Internet]. 2006;33(6):695–704. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33747368960&doi=10.1016%252fj.nucmedbio.2006.05.010&partnerID=40&md5=41fe18b4d3e2fb4db31f31915e3d296c

54.

Levitzki A, Mishani E. Tyrphostins and other tyrosine kinase inhibitors. Annual Review of Biochemistry [Internet]. 2006;75:93–109. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33746347333&doi=10.1146%252fannurev.biochem.75.103004.142657&partnerID=40&md5=36d270f6149f435c548aa7ad165d1f2a

55.

Wald O, Weiss ID, Wald H, Shoham H, Bar-Shavit Y, Beider K, et al. IFN-γ acts on T cells to induce NK cell mobilization and accumulation in target organs. Journal of Immunology [Internet]. 2006;176(8):4716–29. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33645765996&doi=10.4049%252fjimmunol.176.8.4716&partnerID=40&md5=70e67564b1bd7f19319286faa8a12ab7

56.

Even-Sapir E, Metser U, Mishani E, Lievshitz G, Lerman H, Leibovitch I. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F- Fluoride PET/CT. Journal of Nuclear Medicine [Internet]. 2006;47(2):287–97. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33746187320&partnerID=40&md5=99847745252a75ebe56e4ae6d526acd0

57.

Dissoki S, Laky D, Mishani E. Fluorine-18 labeling of ML04 - Presently the most promising irreversible inhibitor candidate for visualization of EGFR in cancer. Journal of Labelled Compounds and Radiopharmaceuticals [Internet]. 2006;49(6):533–43. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33745599854&doi=10.1002%252fjlcr.1071&partnerID=40&md5=fd747419c2fea28d3939acbc384118c0

58.

Jacobson O, Bechor Y, Icar A, Novak N, Birman A, Marom H, et al. Prostate cancer PET bioprobes: Synthesis of [18F]-radiolabeled hydroxyflutamide derivatives. Bioorganic and Medicinal Chemistry [Internet]. 2005;13(22):6195–205. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-25844485927&doi=10.1016%252fj.bmc.2005.06.033&partnerID=40&md5=49ba7a27743e5f7d657515561a2a057a

59.

Freedman NMT, Mishani E, Krausz Y, Weininger J, Lester H, Blaugrund E, et al. In vivo measurement of brain monoamine oxidase B occupancy by rasagiline, using 11C-L-deprenyl and PET. Journal of Nuclear Medicine [Internet]. 2005;46(10):1618–24. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33644672784&partnerID=40&md5=d5a1af90856959aee7ea00d7be1d7f78

60.

Mishani E, Abourbeh G, Jacobson O, Dissoki S, Ben Daniel R, Rozen Y, et al. High-affinity epidermal growth factor receptor (EGFR) irreversible inhibitors with diminished chemical reactivities as positron emission tomography (PET)-imaging agent candidates of EGFR overexpressing tumors. Journal of Medicinal Chemistry [Internet]. 2005;48(16):5337–48. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-23444462507&doi=10.1021%252fjm0580196&partnerID=40&md5=9dd28555fd8d51b9eb433072b6885089

61.

Barda Y, Cohen N, Lev V, Ben-Aroya N, Koch Y, Mishani E, et al. Backbone metal cyclization: Novel 99mTc labeled GnRH analog as potential SPECT molecular imaging agent in cancer. Nuclear Medicine and Biology [Internet]. 2004;31(7):921–33. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-4644260673&doi=10.1016%252fj.nucmedbio.2004.05.003&partnerID=40&md5=df6ad41f9a6954004ebff966514a7272

62.

Shaul M, Abourbeh G, Jacobson O, Rozen Y, Laky D, Levitzki A, et al. Novel iodine-124 labeled EGFR inhibitors as potential PET agents for molecular imaging in cancer. Bioorganic and Medicinal Chemistry [Internet]. 2004;12(13):3421–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-2942549775&doi=10.1016%252fj.bmc.2004.04.044&partnerID=40&md5=bd9199dd5ea51250054d39411296bfb2

63.

Mishani E, Abourbeh G, Rozen Y, Jacobson O, Laky D, David IB, et al. Novel carbon-11 labeled 4-dimethylamino-but-2-enoic acid [4-(phenylamino)-quinazoline-6-yl]-amides: Potential PET bioprobes for molecular imaging of EGFR-positive tumors. Nuclear Medicine and Biology [Internet]. 2004;31(4):469–76. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-1842850604&doi=10.1016%252fj.nucmedbio.2003.12.005&partnerID=40&md5=e14164336c62803cd479da0246f84a87

64.

Even-Sapir E, Metser U, Flusser G, Zuriel L, Kollender Y, Lerman H, et al. Assessment of malignant skeletal disease: Initial experience with 18F-fluoride PET/CT and comparison between18F-fluoride PET and18F-fluoride PET/CT. Journal of Nuclear Medicine [Internet]. 2004;45(2):272–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-1542609199&partnerID=40&md5=c37c7bae6e0e0a1259a7571a0c958d71

65.

Ben-David I, Rozen Y, Ortu G, Mishani E. Radiosynthesis of ML03, a novel positron emission tomography biomarker for targeting epidermal growth factor receptor via the labeling synthon: [11C]acryloyl chloride. Applied Radiation and Isotopes [Internet]. 2003;58(2):209–17. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037318292&doi=10.1016%2fS0969-8043%2802%2900301-9&partnerID=40&md5=11579237fd171edc296e9eadd75f1fd6

66.

Ortu G, Ben-David I, Rozen Y, Freedman NMT, Chisin R, Levitzki A, et al. Labeled EGFr-TK irreversible inhibitor (ML03): In vitro and in vivo properties, potential as pet biomarker for cancer and feasibility as anticancer drug. International Journal of Cancer [Internet]. 2002;101(4):360–70. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036782104&doi=10.1002%252fijc.10619&partnerID=40&md5=5196d03c1c7abc68c860512c05c3532b

67.

Mishani E, Ben-David I, Rozen Y. Improved method for the quality assurance of [C-11]choline. Nuclear Medicine and Biology [Internet]. 2002;29(3):359–62. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036203552&doi=10.1016%2fS0969-8051%2801%2900311-0&partnerID=40&md5=48ffd4a11686478ba3ab55088c8936eb

68.

Bonasera TA, Ortu G, Rozen Y, Krais R, Freedman NMT, Chisin R, et al. Potential 18F-labeled biomarkers for epidermal growth factor receptor tyrosine kinase. Nuclear Medicine and Biology [Internet]. 2001;28(4):359–74. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035016290&doi=10.1016%2fS0969-8051%2801%2900200-1&partnerID=40&md5=49f741391e3a7812cc6134c7d2f58425

69.

Bocher M, Chisin R, Parag Y, Freedman N, Meir Weil Y, Lester H, et al. Cerebral activation associated with sexual arousal in response to a pornographic clip: A 15O-H2O PET study in heterosexual men. NeuroImage [Internet]. 2001;14(1 I):105–17. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034978391&doi=10.1006%252fnimg.2001.0794&partnerID=40&md5=7fd81483dbb6e1adcd3f2ccebeb67a51

70.

Bocher M, Mishani E. The contribution of position emission tomography to the treatment of cancer patients. Harefuah [Internet]. 2000;139(1–2):64–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034221058&partnerID=40&md5=9f6a50d38762dc70352ebc862658fc39

71.

Ben-David I, Rechavi D, Mishani E, Rozen S. A novel synthesis of trifluoromethyl ethers via xanthates, utilizing BrF3. Journal of Fluorine Chemistry [Internet]. 1999;97(1–2):75–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0001797546&doi=10.1016%2fS0022-1139%2899%2900031-7&partnerID=40&md5=e4554eab1c9fdd3fcca309369417ea2a

72.

Mishani E, Lifshits N, Osavistky A, Kaufman J, Ankry N, Tal N, et al. Radiation levels in cyclotron-radiochemistry facility measured by a novel comprehensive computerized monitoring system. Nuclear Instruments and Methods in Physics Research, Section A: Accelerators, Spectrometers, Detectors and Associated Equipment [Internet]. 1999;425(1):332–42. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033116376&doi=10.1016%2fS0168-9002%2898%2901407-7&partnerID=40&md5=21dcea03d47f1270fe5b4563eeb5daba

73.

Mishani E, Bonasera TA, Rozen Y, Ortu G, Gazit A, Levitzki A. Fluorinated EGFR-TK inhibitor-based tracers for PET. Journal of Labelled Compounds and Radiopharmaceuticals [Internet]. 1999;42(SUPPL. 1):S27–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032812411&partnerID=40&md5=724cafc0ee5e723563c74b39c2842ea1

74.

Ben-David I, Mishani E, Rozen S. Tert-Butyl Hypofluorite - An Electrophilic tert-Butoxylation Agent. Journal of Organic Chemistry [Internet]. 1998;63(14):4632–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0346753177&doi=10.1021%252fjo9723366&partnerID=40&md5=e7436cf7fe0716519ca07114fffb3129

75.

Mishani E, Cristel ME, Dence CS, McCarthy TJ, Welch MJ. Application of a novel phenylpiperazine formation reaction to the radiosynthesis of a model fluorine-18-labeled radiopharmaceutical (18FTFMPP). Nuclear Medicine and Biology [Internet]. 1997;24(3):269–73. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030738287&doi=10.1016%2fS0969-8051%2897%2900063-2&partnerID=40&md5=90c7feb5f5f9d226b3f901af1f5a91f3

76.

Mishani E, Dence CS, McCarthy TJ, Welch MJ. Formation of phenylpiperazines by a novel alumina supported bis-alkylation. Tetrahedron Letters [Internet]. 1996;37(3):319–22. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030040462&doi=10.1016%2f0040-4039%2895%2902162-0&partnerID=40&md5=155c6112be578fb9957923cd9ffae3b9

77.

Rozen S, Mishani E. A novel method for converting aromatic acids into trifluoromethyl derivatives using BrF3. Journal of the Chemical Society, Chemical Communications [Internet]. 1994;(18):2081. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028001346&doi=10.1039%252fC39940002081&partnerID=40&md5=b07cf42c40a8dc417e72a67209f7b321

78.

Rozen S, Bar-Haim A, Mishani E. Fluorination of Nitro Compounds with Acetyl Hypofluorite. Journal of Organic Chemistry [Internet]. 1994;59(22):6800–3. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-20444439973&doi=10.1021%252fjo00101a047&partnerID=40&md5=ae26db0800877ecfdffaf27fc428a3d2

79.

Rozen S, Mishani E, Kol M, Ben-David I. The Chemistry of Methyl Hypofluorite: Its Reactions with Various Unsaturated Centers. Journal of Organic Chemistry [Internet]. 1994;59(15):4281–4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0000705621&doi=10.1021%252fjo00094a047&partnerID=40&md5=d027677b3458a5f10c9bc8a03d97cf7c

80.

Rozen S, Mishani E, Bar-Haim A. A Novel Carbonyl to CF2 Transformation Using BrF3. Journal of Organic Chemistry [Internet]. 1994;59(11):2918. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0000235194&doi=10.1021%252fjo00090a002&partnerID=40&md5=2d083f5146f1e773b8b750ba88b390ce

81.

Rozen S, Bar-Haim A, Mishani E. New Efficient Route to α-Nitro Acids. Oxidation of Amino Acids with HOF·CH3CN. Journal of Organic Chemistry [Internet]. 1994;59(5):1208–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0038140437&doi=10.1021%252fjo00084a047&partnerID=40&md5=f6472559eda494a4be1417b30501367f

82.

Rozen S, Mishani E. Conversion of esters to α,α-difluoro ethers using bromine trifluoride. Journal of the Chemical Society, Chemical Communications [Internet]. 1993;(23):1761–2. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-37049068205&doi=10.1039%252fC39930001761&partnerID=40&md5=dbe1cc7703488d1ed397b10ffa874547

83.

Appelman EH, French D, Mishani E, Rozen S. Synthesis, Characterization, and Reaction Chemistry of tert-Butyl Hypofluorite. Journal of the American Chemical Society [Internet]. 1993;115(4):1379–82. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0038228730&doi=10.1021%252fja00057a022&partnerID=40&md5=9b5033c7dcbf877cfc2141b24776800e

84.

Rozen S, Mishani E, Kol M. A Novel Electrophilic Methoxylation (with a Little Help from F2). Journal of the American Chemical Society [Internet]. 1992;114(20):7643–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0011971475&doi=10.1021%252fja00046a006&partnerID=40&md5=1bba020225f94eb724b14519e9246aff